ATP5PO and cancer: The identification of peptides targeting the IF1–OSCP subunit interaction, and causing the IF1 displacement from the binding site on the OSCP subunit, which exerts a pro-survival effect in cancer cells, might represent a new strategy for developing anti-cancer therapy.